Itamar Medical has announced the appointment of Gilad Glick as the company CEO, effective July 1, 2013. Dr. Dov Rubin, who served as CEO for the past five years, will step down. Before Gilad joined Itamar, he served as Vice President Worldwide Sales and Marketing as well as a senior member of the Biosense Webster management team-- the cardiovascular division of Johnson & Johnson.